Botulinum toxin type A in pregnancy
Abstract
Botulinum toxin is not expected to be present in systemic circulation following proper intramuscular or intradermal injection. Moreover, BTX-A, which has a high molecular weight, does not appear to cross the placenta. From the 38 pregnancies reported in the literature, including women who had botuli …
Keywords
injections
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
female
intramuscular
maternal-fetal exchange*
botulinum toxins
pmid:24235190
pmc3828093
michael tan
eunji kim
pina bozzo
type a / adverse effects*
type a / metabolism
intradermal
neuromuscular agents / adverse effects*
neuromuscular agents / metabolism
prenatal exposure delayed effects / prevention & control*
skin aging
Access
Citation
ID:
261736
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
261736
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet